tiprankstipranks
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM
US Market
AXSM
Axsome Therapeutics
RESEARCH TOOLSreports

Axsome Therapeutics (AXSM) Income Statement

2,347 Followers

Axsome Therapeutics Income Statement

Last quarter (Q4 2025), Axsome Therapeutics's total revenue was $196.00M, an increase of 65.03% from the same quarter last year. In Q4, Axsome Therapeutics's net income was $-28.56M. See Axsome Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 638.50M$ 385.69M$ 270.60M$ 50.04M$ 0.00
Gross Profit
$ 591.02M$ 352.39M$ 244.53M$ 44.84M$ 0.00
Operating Expenses
$ 760.25M$ 632.95M$ 476.36M$ 224.64M$ 124.71M
Depreciation and Amortization
$ 9.06M$ 7.96M$ 6.83M$ 4.40M$ 76.00K
EBITDA
$ -168.08M$ -272.60M$ -224.99M$ -175.40M$ -124.63M
Operating Income
$ -169.24M$ -280.56M$ -231.82M$ -179.80M$ -124.71M
Other Income/Expenses
$ -14.47M$ -6.57M$ -6.45M$ -7.33M$ -5.70M
Pretax Income
$ -183.70M$ -287.13M$ -238.28M$ -187.13M$ -130.40M
Net Income
$ -183.17M$ -287.22M$ -239.24M$ -187.13M$ -130.40M
Per Share Metrics
Basic EPS
$ -3.68$ -5.99$ -5.27$ -4.60$ -3.47
Diluted EPS
$ -3.68$ -5.99$ -5.27$ -4.60$ -3.47
Weighted Average Shares Outstanding
 49.75M 47.91M 45.43M 40.66M 37.62M
Weighted Average Shares Outstanding (Diluted)
 49.75M 47.91M 45.43M 40.66M 37.62M
Currency in USD

Axsome Therapeutics Earnings and Revenue History